Global Drug-eluting Stent Market 2014-2018 - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-04-11 09:09:01
The Global Drug-eluting Stent (DES) market is forecast to grow at a CAGR of 5.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global Drug-eluting Stent (DES) market has also been witnessing the increasing demand for minimally invasive procedures. However, the decline in the average selling price of drug eluting stents could pose a challenge to the growth of this market.
Key vendors dominating this space are Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., and Terumo Corp.
Other vendors mentioned in the report are B. Braun Melsungen AG, Biosensors International Ltd., BIOTRONIK SE & Co. KG, Cook Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corp., and Sorin Group USA Inc.
The following companies represent the key players in Global Drug-eluting Stent Market: Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., and Terumo Corp.
Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries.
One of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD.
Further, the biggest challenge the market is facing is the decline in the ASP of DESs. There has been a steady decline in the prices of DESs worldwide because of the increased competition and the high rate of adoption. The reduction in the ASP has a negative impact on the overall market revenue.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.